Clinical Trials Browser

Completed × INDUSTRY × viscum album peptide × Clear all

NCT02007005 2015-05-06

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Phase 1/2 Completed

Non-Muscle Invasive Bladder Neoplasms

NCT02191540 2014-07-23

Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients

Phase 3 Completed

Pleural Effusion, Malignant